Microsoft is partnering with San Francisco-based Pangaea Data to integrate Dragon Copilot into the company’s clinical AI platform, building upon a “breakout” year for the technology.
The collaboration brings Microsoft’s speech recognition and generative AI tools to bear on Pangaea’s existing platform, which emulates manual EHR review processes and identifies untreated and under-treated patients across hard-to-diagnose conditions. These include chronic kidney disease, cancer cachexia, chronic obstructive pulmonary disease and rare diseases.
By combining technologies, the integration aims to deliver real-time insights from patient conversations, reduce time to diagnosis, and support more guideline-directed treatments. Clinicians will be able to access these insights and initiate clinical actions — such as scheduling follow-ups or updating records — without leaving their native workflows.
Microsoft said the effort is part of a broader push to embed ambient AI into care delivery without disrupting existing processes. In the fourth quarter of the 2025 fiscal year, Microsoft reported more than 13 million patient encounters using the Dragon Copilot after expanding the technology to support nursing and third party partner integrations last year.
